Table 3—

Spearman correlation coefficients* between prevalence of the metabolic syndrome and prevalence of individual metabolic disorders across populations

Prevalence of ATP III–defined metabolic syndromePrevalence of IDF-defined metabolic syndrome
Prevalence of elevatedwaist circumference using ATP III cutoff points0.47 (P = 0.205)0.57 (P = 0.112)
Prevalence of elevated waist circumference using IDF cutoff points0.70 (P = 0.036)0.80 (P = 0.009)
Prevalence of hypertriglyceridemia0.72 (P = 0.029)0.79 (P = 0.011)
Prevalence of low HDL cholesterol0.91 (P < 0.001)0.86 (P = 0.003)
Prevalence of high blood pressure0.12 (P = 0.752)0.12 (P = 0.764)
Prevalence of elevated fasting glucose−0.34 (P = 0.363)−0.24 (P = 0.534)
  • * Sex was considered a partial variable.

  • Men and women were considered separately.